cow urine use for cancer

In all 150 male and 100 felale patients of age between 23 years to 82 years with the mean age of 50.76 years had been treated as under.

Name of disease	No. of patients	Average age of patient	Average duration of disease	Average Time of relief
Ovarian Tumour	10	61 years	2 years	2.5 months
Benign Prostatic Hypertrophy	20	61.5 years	1.5 years	3.8 months
Renal Cell Carcinoma	10	68 years	2 years	2.8 months
Breast Cancer	50	45 years	3.66 years	3.5 months
CLL	20	60.5 years	3.41 years	2 months
Tubercullar Lymphadenopathy	10	34 years	10 years	1.9 months
Cervical Cancer	10	56 years	3 years	3.2 months
Uterine Fibroid	20	41.5 years	2 years	2.2 months
Prostate Cancer	10	62 years	1 year	3.1 months
Urinary Bladder Cancer	10	55 years	1 year	3.5 months
Neurofibroma	10	39 years	25 years	1.8 months
Throat Cancer	20	64 years	0.54 year	3.4 months
Sub Mucous Fibrosis	30	35.66 years	4.33 years	2.4 months
Oral Cancer	20	53.3 years	3 years	3.6 months
Acute lymphoblastic Cancer	15	35 years	3 years	2.3 months
Cancer (Benign or malignant)	250	50.76 years	3.84 years	2.8 months

The above study was based on the symptomatic relief found to the patient undergoing our treatment. The symptomatic relief signifies the improvement in physical conditions like low diet, difficulty in swallowing, constipation, vomiting, sever pain and other problems. Further various researches have been done and going on which signifies its role as follows:

(US Patent #6410059): Cow Urine in a specific amount is scientifically proven to enhance the anti-microbial effects of antibiotic and antifungal agents. The invention relates to a novel use of cow urine as activity enhancer and availability facilitator for bioactive molecules, including anti-infective agents. The invention has direct implication in drastically reducing the dosage of antibiotics, drugs and anti-infective agent while increasing the efficiency of absorption of bio-active molecules, thereby reducing the cost of treatment and also the side-effects due to toxicity.
(US Patents #6896907, #7235262): Use of bioactive fraction from cowurine (`go-mutra`) as a bio-enhancer of anti-infective, anti-cancer agents and nutrients. The invention relates to a novel pharmaceutical composition comprising an effective amount of bio-active fraction from cow urine as a bioavailability facilitator and pharmaceutically acceptable additives selected from anticancer compounds, antibiotics, drugs, therapeutic and nutraceutic agents, ions and similar molecules which are targeted to the living systems.

Hence it heps in reducing the growth of cancer cells, improving the quality of life and life expectancy

of the patient.